The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
Open accessAbstract
Potential conflict of interest: Dr. Bodewes advises Vertex. Dr. Strazzabosco advises Bayer and Engitix. The current pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to over 6 million cases and over 370,000 deaths as of June 1, 2020.(1) Although most patients infected with SARS‐CoV‐2 develop only mild symptoms, a minority of patients require hospitalization and intensive care.(2) Based on the available clinical data, abnormal liver function tests (LFTs) are frequently observed in patients with coronavirus disease 2019 (COVID‐19), of which the underlying pathogenesis is incompletely understood. We reviewed the available information on the prevalence, nature, relevance, and the potential pathogenesis of altered LFTs in patients with COVID‐19. Epidemiology of Abnormal LFTs in Patients With COVID‐19 Liver function tests include measures of hepatocyte injury (aspartate transferase [AST] and alanine transferase [ALT]), bile duct injury or cholestasis (alkaline phosphatase [ALP] and gamma‐glutamyltransferase [GGT]), markers of hepatic clearance/biliary secretion capacity (bilirubin), as well as measures of synthetic capacity (prothrombin time and albumin). LFTs are not necessarily liver‐specific. It has been suggested that elevated aminotransferases in COVID‐19 could also originate from myositis rather than liver injury.(3) In a large descriptive study, the muscle damage marker creatinine kinase was elevated in 14% of patients with COVID‐19.(4) Hypoalbuminemia was reported in 55% of hospitalized patients with COVID‐19(5) and was associated with disease severity.(6) Hypoalbuminemia was an independent predictor of mortality.(7) Lower levels of pre‐albumin in patients with severe COVID‐19 were reported, suggesting decreased hepatic synthesis.(5) In the context of inflammation, hypoalbuminemia may also reflect albumin extravasation as a consequence of increased capillary permeability.(8) Additional factors that could explain the observed hypoalbuminemia in severe COVID‐19 are increased catabolism and malnutrition. The prevalence of ALT elevations among patients with COVID‐19 ranged between 4% and 33% in Chinese cohorts (weighted average: 19%), but was as high as 39% in a large cohort from the New York City area(5,9‐21) (Fig. 1). ALT elevations were generally mild, defined as less than 5 times the upper reference limit.(9,10,14‐19,21‐34) The prevalence of AST elevations ranged between 4% and 53% in Chinese cohorts (weighted average: 21%) and was 58% in the US cohort(4,5,9‐16,18,19,21,22,24,25,29,34,35) (Fig. 1). AST elevations were similarly less than 5 times the upper reference limit.(9,10,14‐16,18,19,21‐31,34,36) AST and ALT elevations had also been reported in patients with SARS caused by SARS‐CoV.(37) Several case reports have described severe LFT abnormalities(18,38,39) or acute‐on‐chronic(40,41) liver failure in patients with COVID‐19. Zhang et al.(33) reported that 1 of 82 deceased patients with COVID‐19 had a hepatic cause of death, although it was not clear whether this patient had pre‐existing liver disease.FIG. 1: Percentage of hospitalized COVID‐19 patients with AST or ALT elevations on admission. The studies summarized included patients with all levels of disease severity. The size of the dots reflects the relative number of patients included in each study. The upper panels represent Chinese cohorts, whereas the lower panel represents a US cohort. The weighted averages are represented by the vertical black lines and refer to the Chinese cohorts.Elevated ALP was reported in 2%‐5% of patients,(5,11,25,42) and elevated GGT was reported in 13%‐54% of patients (weighted average: 23%).(5,11,19,42) The prevalence of total bilirubin elevations ranged between 1% and 18% of patients with COVID‐19 on admission.(4,5,15,16,18,25,35,43) It should be realized, however, that pre‐existing liver disease was not comprehensively described in any of these studies. Stratification of patients with COVID‐19 according to disease severity, including the extent of respiratory distress and the need for intensive care unit (ICU) admission, indicated that plasma ALT and AST were elevated more frequently and to a greater extent in patients with severe COVID‐19 compared to those with mild disease.(4,5,9,14,22,23,29,31,43‐47) This was also the case for patients with SARS during the 2002‐2004 SARS outbreak.(37) The prognostic value of abnormal LFTs in COVID‐19 is unclear. Some studies found that abnormal LFTs, particularly elevated AST and (peak) ALT, are associated with increased disease severity and mortality,(17,20,46,47) whereas other studies did not find an association with mortality,(48) disease progression,(5) ICU admission,(27,48) or length of hospital stay.(11) Potential Pathogenesis of Abnormal Liver Function Tests in Patients With COVID‐19 Hepatic Infection With SARS‐CoV‐2 SARS‐CoV‐2 uses the angiotensin‐converting enzyme 2 (ACE2) as docking and entry receptor on host cells.(49) Transmem
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020) · JAMA · doi:10.1001/jama.2020.3786 · Cited by 5,028
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., Fan, Y., & Zheng, C. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30086-4 · Cited by 3,664
Kidney disease is associated with in-hospital death of patients with COVID-19
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.005 · Cited by 2,941
Evidence for gastrointestinal infection of SARS-CoV-2
Xiao, F., Tang, M., Zheng, X., Liu, Y., Li, X., & Shan, H. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.055 · Cited by 2,836
Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0754-0 · Cited by 2,287
Clinical Characteristics of Covid-19 in New York City
Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Nahid, M., Ringel, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010419 · Cited by 2,234
Simonnet, A., Chetboun, M., Poissy, J., Raverdy, V., Noulette, J., Duhamel, A., Labreuche, J., Mathieu, D., Pattou, F., Jourdain, M., et al. (2020) · Obesity · doi:10.1002/oby.22831 · Cited by 2,079
Xu, X.-W., Wu, X.-X., Jiang, X.-G., Xu, K.-J., Ying, L.-J., Ma, C.-L., Li, S.-B., Wang, H.-Y., Zhang, S., Gao, H.-N., et al. (2020) · BMJ · doi:10.1136/bmj.m606 · Cited by 2,046
Liver enzyme alteration: a guide for clinicians
Giannini, E. G. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040752 · Cited by 2,016
Liver injury in COVID-19: management and challenges
Zhang, C., Shi, L., & Wang, F.-S. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30057-1 · Cited by 1,906
Zhang, W., Du, R.-H., Li, B., Zheng, X.-S., Yang, X.-L., Hu, B., Wang, Y.-Y., Xiao, G.-F., Yan, B., Shi, Z.-L., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1729071 · Cited by 1,799
Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102763 · Cited by 1,702
SARS-CoV-2 productively infects human gut enterocytes
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., Paul van Schayck, J., Mykytyn, A. Z., Duimel, H. Q., et al. (2020) · Science · doi:10.1126/science.abc1669 · Cited by 1,573
Hypoalbuminemia: Pathogenesis and Clinical Significance
Soeters, P. B., Wolfe, R. R., & Shenkin, A. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1451 · Cited by 1,448 · cited 1×
“(5) In the context of inflammation, hypoalbuminemia may also reflect albumin extravasation as a consequence of increased capillary permeability.(8) Additional factors that could explain the observed hypoalbuminemia in severe COVID-19 are increased catabolism and malnutrition.”
BackgroundRemdesivir for the Treatment of Covid-19 — Preliminary Report
(2020) · New England Journal of Medicine · doi:10.1056/nejmc2022236 · Cited by 1,396
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Goldman, J. D., Lye, D. C. B., Hui, D. S., Marks, K. M., Bruno, R., Montejano, R., Spinner, C. D., Galli, M., Ahn, M.-Y., Nahass, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015301 · Cited by 1,362
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Albillos, A., Lario, M., & Álvarez-Mon, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.010 · Cited by 1,242 · cited 1×
“Patients with advanced liver disease are generally at an increased risk of infection due to cirrhosis-associated immune dysfunction.(84) Another patient category that raises concerns is liver transplant recipients and patients with auto-immune liver disease receiving immunosuppressant drugs.”
BackgroundCOVID-19 cytokine storm: the interplay between inflammation and coagulation
Jose, R. J., & Manuel, A. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30216-2 · Cited by 1,240
Menter, T., Haslbauer, J. D., Nienhold, R., Savic, S., Hopfer, H., Deigendesch, N., Frank, S., Turek, D., Willi, N., Pargger, H., et al. (2020) · Histopathology · doi:10.1111/his.14134 · Cited by 1,230
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Mao, R., Qiu, Y., He, J.-S., Tan, J.-Y., Li, X.-H., Liang, J., Shen, J., Zhu, L.-R., Chen, Y., Iacucci, M., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30126-6 · Cited by 1,056
COVID-19: Abnormal liver function tests
Cai, Q., Huang, D., Yu, H., Zhu, Z., Xia, Z., Su, Y., Li, Z., Zhou, G., Gou, J., Qu, J., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.006 · Cited by 1,047
Borba, M. G. S., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., Brito, M., Mourão, M. P. G., Brito-Sousa, J. D., Baía-da-Silva, D., Guerra, M. V. F., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8857 · Cited by 1,038
The protein expression profile of ACE2 in human tissues
Hikmet, F., Méar, L., Edvinsson, Å., Micke, P., Uhlén, M., & Lindskog, C. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209610 · Cited by 1,016
Yang, W., Cao, Q., Qin, L., Wang, X., Cheng, Z., Pan, A., Dai, J., Sun, Q., Zhao, F., Qu, J., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.016 · Cited by 989
Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., Lang, C., Huang, D., Sun, Q., Xiong, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25783 · Cited by 982
Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection
Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., Zhou, J., Shi, G., Fang, N., Fan, J., et al. (2020) · doi:10.1101/2020.02.03.931766 · Cited by 952
Clinical Features of COVID-19-Related Liver Functional Abnormality
Fan, Z., Chen, L., Li, J., Cheng, X., Yang, J., Tian, C., Zhang, Y., Huang, S., Liu, Z., & Cheng, J. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.002 · Cited by 921
Qi, F., Qian, S., Zhang, S., & Zhang, Z. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.044 · Cited by 905 · cited 1×
“Single-cell RNA-sequencing approaches indicated that ACE2 mRNA is expressed in a subpopulation of cholangiocytes, not or minimally in hepatocytes, and not in any other liver cell type.(52-55) In line with this, at the protein level, ACE2 was visualized by immunohistochemistry in a subset of cholangiocytes, but not in…”
BackgroundClinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China
Mo, P., Xing, Y., Xiao, Y., Deng, L., Zhao, Q., Wang, H., Xiong, Y., Cheng, Z., Gao, S., Liang, K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa270 · Cited by 853
Clinical progression of patients with COVID-19 in Shanghai, China
Chen, J., Qi, T., Liu, L., Ling, Y., Qian, Z., Li, T., Li, F., Xu, Q., Zhang, Y., Xu, S., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.004 · Cited by 789
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China
Cai, Q., Chen, F., Wang, T., Luo, F., Liu, X., Wu, Q., He, Q., Wang, Z., Liu, Y., Liu, L., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0576 · Cited by 706
Akhmerov, A., & Marbán, E. (2020) · Circulation Research · doi:10.1161/circresaha.120.317055 · Cited by 693
Clinical characteristics of 82 cases of death from COVID-19
Zhang, B., Zhou, X., Qiu, Y., Song, Y., Feng, F., Feng, J., Song, Q., Jia, Q., & Wang, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0235458 · Cited by 683
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
D’Antiga, L. (2020) · Liver Transplantation · doi:10.1002/lt.25756 · Cited by 664
Wu, J., Liu, J., Zhao, X., Liu, C., Wang, W., Wang, D., Xu, W., Zhang, C., Yu, J., Jiang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa199 · Cited by 626
Wang, Y., Liu, S., Liu, H., Li, W., Lin, F., Jiang, L., Li, X., Xu, P., Zhang, L., Zhao, L., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.002 · Cited by 626
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
Ji, D., Qin, E., Xu, J., Zhang, D., Cheng, G., Wang, Y., & Lau, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.044 · Cited by 525
COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z., Su, Y., Ma, Z., Zhang, Y., Li, Z., et al. (2020) · Allergy · doi:10.1111/all.14309 · Cited by 502
Zhao, D., Yao, F., Wang, L., Zheng, L., Gao, Y., Ye, J., Guo, F., Zhao, H., & Gao, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa247 · Cited by 488
COVID-19 and the liver: little cause for concern
Bangash, M. N., Patel, J., & Parekh, D. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30084-4 · Cited by 481
Obesity Is a Risk Factor for Greater COVID-19 Severity
Gao, F., Zheng, K. I., Wang, X.-B., Sun, Q.-F., Pan, K.-H., Wang, T.-Y., Chen, Y.-P., Targher, G., Byrne, C. D., George, J., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0682 · Cited by 476
Clinical Characteristics of Covid-19 in China
(2020) · New England Journal of Medicine · doi:10.1056/nejmc2005203 · Cited by 475
Zhang, Y., Zheng, L., Liu, L., Zhao, M., Xiao, J., & Zhao, Q. (2020) · Liver International · doi:10.1111/liv.14455 · Cited by 471
Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019
Kalligeros, M., Shehadeh, F., Mylona, E. K., Benitez, G., Beckwith, C. G., Chan, P. A., & Mylonakis, E. (2020) · Obesity · doi:10.1002/oby.22859 · Cited by 442
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
Lei, F., Liu, Y., Zhou, F., Qin, J., Zhang, P., Zhu, L., Zhang, X., Cai, J., Lin, L., Ouyang, S., et al. (2020) · Hepatology · doi:10.1002/hep.31301 · Cited by 430
Wang, H., & Ma, S. (2008) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2007.10.031 · Cited by 408
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
Zhao, B., Ni, C., Gao, R., Wang, Y., Yang, L., Wei, J., Lv, T., Liang, J., Zhang, Q., Xu, W., et al. (2020) · Protein & Cell · doi:10.1007/s13238-020-00718-6 · Cited by 399
Qian, G. Q., Yang, N. B., Ding, F., Ma, A. H. Y., Wang, Z. Y., Shen, Y. F., Shi, C. W., Lian, X., Chu, J. G., Chen, L., et al. (2020) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcaa089 · Cited by 382
Phipps, M. M., Barraza, L. H., LaSota, E. D., Sobieszczyk, M. E., Pereira, M. R., Zheng, E. X., Fox, A. N., Zucker, J., & Verna, E. C. (2020) · Hepatology · doi:10.1002/hep.31404 · Cited by 355
Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)
Luo, S., Zhang, X., & Xu, H. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.03.043 · Cited by 348
Hypoalbuminemia predicts the outcome of COVID‐19 independent of age and co‐morbidity
Huang, J., Cheng, A., Kumar, R., Fang, Y., Chen, G., Zhu, Y., & Lin, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26003 · Cited by 335
Zheng, K. I., Gao, F., Wang, X.-B., Sun, Q.-F., Pan, K.-H., Wang, T.-Y., Ma, H.-L., Chen, Y.-P., Liu, W.-Y., George, J., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154244 · Cited by 332
Duarte‐Neto, A. N., Monteiro, R. A. A., da Silva, L. F. F., Malheiros, D. M. A. C., de Oliveira, E. P., Theodoro‐Filho, J., Pinho, J. R. R., Gomes‐Gouvêa, M. S., Salles, A. P. M., de Oliveira, I. R. S., et al. (2020) · Histopathology · doi:10.1111/his.14160 · Cited by 327
Redd, W. D., Zhou, J. C., Hathorn, K. E., McCarty, T. R., Bazarbashi, A. N., Thompson, C. C., Shen, L., & Chan, W. W. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.045 · Cited by 313
Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism
Lefere, S., & Tacke, F. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.02.004 · Cited by 278
Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations
Sonzogni, A., Previtali, G., Seghezzi, M., Grazia Alessio, M., Gianatti, A., Licini, L., Morotti, D., Zerbi, P., Carsana, L., Rossi, R., et al. (2020) · Liver International · doi:10.1111/liv.14601 · Cited by 266
SARS-CoV-2 Productively Infects Human Gut Enterocytes
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., van Schayck, J. P., Mykytyn, A. Z., Duimel, H. Q., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.25.060350 · Cited by 259
COVID-19 and the role of chronic inflammation in patients with obesity
Chiappetta, S., Sharma, A. M., Bottino, V., & Stier, C. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0597-4 · Cited by 259
Wang, R., Pan, M., Zhang, X., Han, M., Fan, X., Zhao, F., Miao, M., Xu, J., Guan, M., Deng, X., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.070 · Cited by 244
Huang, Y., Tu, M., Wang, S., Chen, S., Zhou, W., Chen, D., Zhou, L., Wang, M., Zhao, Y., Zeng, W., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101606 · Cited by 229
Hernandez, A. V., Roman, Y. M., Pasupuleti, V., Barboza, J. J., & White, C. M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2496 · Cited by 222
Aziz, M., Fatima, R., Lee-Smith, W., & Assaly, R. (2020) · Critical Care · doi:10.1186/s13054-020-02995-3 · Cited by 210
Obesity is Associated with Worse Outcomes in COVID‐19: Analysis of Early Data from New York City
Hajifathalian, K., Kumar, S., Newberry, C., Shah, S., Fortune, B., Krisko, T., Ortiz‐Pujols, S., Zhou, X. K., Dannenberg, A. J., Kumar, R., et al. (2020) · Obesity · doi:10.1002/oby.22923 · Cited by 204
Targher, G., Mantovani, A., Byrne, C. D., Wang, X.-B., Yan, H.-D., Sun, Q.-F., Pan, K.-H., Zheng, K. I., Chen, Y.-P., Eslam, M., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321611 · Cited by 203
Oyelade, T., Alqahtani, J., & Canciani, G. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5020080 · Cited by 187
Xiong, M., Liang, X., & Wei, Y. (2020) · British Journal of Haematology · doi:10.1111/bjh.16725 · Cited by 174
Acetaminophen‐induced liver injury in obesity and nonalcoholic fatty liver disease
Michaut, A., Moreau, C., Robin, M., & Fromenty, B. (2014) · Liver International · doi:10.1111/liv.12514 · Cited by 171
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis
Mantovani, A., Beatrice, G., & Dalbeni, A. (2020) · Liver International · doi:10.1111/liv.14465 · Cited by 170
SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects
Michalakis, K., & Ilias, I. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.033 · Cited by 162
Parohan, M., Yaghoubi, S., & Seraj, A. (2020) · Hepatology Research · doi:10.1111/hepr.13510 · Cited by 158
Zhou, Y., Zheng, K. I., Wang, X., Yan, H.-D., Sun, Q., Pan, K.-H., Wang, T.-Y., Ma, H., Chen, Y.-P., George, J., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.027 · Cited by 135
Diamanti, A. P., Rosado, M. M., Pioli, C., Sesti, G., & Laganà, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093330 · Cited by 133
Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, ChinaPreprint
Huang, Y., Yang, R., Xü, Y., & Gong, P. (2020) · medRxiv · doi:10.1101/2020.02.27.20029009 · Cited by 131
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity
INSERM, U., & Fromenty, B. (2017) · Journal of Clinical and Translational Research · doi:10.18053/jctres.03.2017s1.006 · Cited by 129
COVID-19 Presenting as Acute Hepatitis
Wander, P., Epstein, M. E., & Bernstein, D. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000660 · Cited by 121
Pirola, C. J., & Sookoian, S. C. (2020) · Liver International · doi:10.1111/liv.14500 · Cited by 113
Qi, X., Liu, C., Jiang, Z., Gu, Y., Zhang, G., Shao, C., Yue, H., Chen, Z., Ma, B., Liu, D., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.010 · Cited by 102
Risk factors related to hepatic injury in patients with corona virus disease 2019Preprint
Lu, L., Li, S., Xu, M., Yu, P., Zheng, S., Duan, Z., Liu, J., Chen, Y., & Li, J. (2020) · medRxiv · doi:10.1101/2020.02.28.20028514 · Cited by 100
Congestive hepatopathy and hypoxic hepatitis in heart failure: A cardiologist's point of view
Kavoliūnienė, A., Vaitiekienė, A., & Čėsnaitė, G. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.05.003 · Cited by 99
COVID-19 in Liver Transplant Recipients: An Initial Experience From the US Epicenter
Lee, B. T., Perumalswami, P., Im, G. Y., Florman, S. S., Schiano, T. D., Da, B. L., Mitchell, R. A., & Kilaru, S. M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.050 · Cited by 99
Severe liver failure during SARS-CoV-2 infection
Weber, S., Mayerle, J. V., Irlbeck, M., & Gerbes, A. L. (2020) · Gut · doi:10.1136/gutjnl-2020-321350 · Cited by 71
Management of patients with autoimmune liver disease during COVID-19 pandemic
Lleò, A., Invernizzi, P., Lohse, A. W., Aghemo, A., & Carbone, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.002 · Cited by 63
Cao, W., Shi, L., Chen, L., Xu, X., & Wu, Z. (2020) · medRxiv · doi:10.1101/2020.02.23.20026963 · Cited by 62
Lippi, G., de Oliveira, M. H. S., & Henry, B. M. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001742 · Cited by 56
Qiu, H., Wander, P., Bernstein, D., & Satapathy, S. K. (2020) · Liver International · doi:10.1111/liv.14506 · Cited by 44
Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2
Smet, V. D., Verhulst, S., & van Grunsven, L. A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.030 · Cited by 39
SARS-CoV-2 related liver impairment – perception may not be the reality
Philips, C. A., Ahamed, R., & Augustine, P. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.025 · Cited by 35
Cui, H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i11.1652 · Cited by 28
SARS‐CoV‐2 as an extrahepatic precipitator of acute‐on‐chronic liver failure
Große, K., Kramer, M., Trautwein, C., & Bruns, T. (2020) · Liver International · doi:10.1111/liv.14540 · Cited by 15
Liver Dysfunction in Critically Ill Patients
Newton, J. M., Aronsohn, A. I., & Jensen, D. M. (2015) · Springer eBooks · doi:10.1007/978-1-4614-7836-2_47 · Cited by 2
Cited by
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Stefan, N., Birkenfeld, A. L., & Schulze, M. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00462-1 · Cited by 452
Pathophysiological mechanisms of liver injury in COVID‐19
Nardo, A. D., Schneeweiss‐Gleixner, M., Bakail, M., Dixon, E. D., Lax, S. F., & Trauner, M. (2021) · Liver International · doi:10.1111/liv.14730 · Cited by 397
Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
Altay, O., Arif, M., Li, X., Yang, H., Aydın, M., Alkurt, G., Kim, W., Akyol, D., Zhang, C., Dinler‐Doganay, G., et al. (2021) · Advanced Science · doi:10.1002/advs.202101222 · Cited by 88
Epigenetic Regulation of Kupffer Cell Function in Health and Disease
Bennett, H., Troutman, T. D., Sakai, M., & Glass, C. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609618 · Cited by 66
Metadata
- Authors
- Bertolini, A., van de Peppel, I. P., Bodewes, F. A. J. A., Moshage, H., Fantin, A., Farinati, F., Fiorotto, R., Jonker, J. W., Strazzabosco, M., Verkade, H. J., & Peserico, G.
- Venue
- Hepatology
- Published
- 2020-10-20
- Volume
- 72
- Issue
- 5
- Pages
- 1864-1872
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W3044536727
- Cited by
- 293
- References
- 107
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.